Endoscopic stomach cancer screening based on the high risk strategy

Gastroenterological Endoscopy

Volumn 49, Issue 9, 2007, Pages 2451-2461

  Miki, Kazumasa ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEPSINOGEN;

ARTICLE; ATROPHIC GASTRITIS; CANCER MORTALITY; CONTROLLED STUDY; FOLLOW UP; GASTROSCOPY; HAZARD RATIO; HUMAN; RISK ASSESSMENT; SCREENING; STOMACH CANCER; X RAY;

EID: 35348989315     PISSN: 03871207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Japanese source
2. Japanese source
3. Japanese source
4. Japanese source
5. Japanese source
6. Miki K, Ichinose M, Shimizu A et al. Serum pepsinogen as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987 ; 22 : 133-41.
7. Miki K, Ichinose M, Kawamura N et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989 ; 80 : 111-4.
8. Miki K, Ichinose M, Ishikawa BK et al. Clinical application of serum pepsinogen I and II levels as mass screening to detect gastric cancer. Jpn J Cancer Res 1993 ; 84 : 1086-90.
9. Hattori Y, Tashiro H, Kawamoto T et al. Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens. Jpn J Cancer Res 1995 ; 86 : 1210-5.
10. Kitahara F, Kobayashi K, Sato T et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999 ; 44 : 693-7.
11. Miki K, Morita M, Sasajima M et al. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003 ; 98 : 735-9.
12. Watabe H, Mitsushima T, Yamaji Y et al. Predicting the developument of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status, a prospective endoscopic cohort study. Gut 2005 ; 54 : 764-8.
13. Ohata H, Oka M, Yanaoka K et al. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci 2005 ; 96 : 713-20.
14. Japanese source
15. Japanese source
16. Japanese source
17. Yoshihara M, Hiyama T, Yoshida S et al. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration : A case-control study. Scand J Gastroenterol 2007 ; 42 : 760-4.
18. Dinis-Ribeiro M, Yamaki G, Miki K et al. Meta -analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004 ; 11 : 141-7.
19. Japanese source
20. Miki K, Ichinose M, Kakei N et al. The clinical application of the serum pepsinogen I and II levels as mass screening method for gastric cancer. Asparttic Proteinases : Structure, Function, Biology and Biomedical Implications, ed Takahashi K, Plenum Press, New York 1995 ; 139-43.
21. Yuan Y, Sun L, Gong Y et al. Population-based screening of gastric cancer in China using both "serum biopsy" and "gastric biopsy". Proceeding of APDW 2007 Kobe 2007.
22. Oshima A, Hirata N, Ubukata T et al. Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 1986 ; 38 : 829-33.
23. Fukao A, Tsubono Y, Tsuji I et al. The evaluation of screening for gastric cancer in Miyagi Prefecture. Japan : a population-based case-control study. Int J Cancer 1995 ; 60 : 45-8.
24. Japanese source
25. Japanese source
26. Japanese source
27. Japanese source
28. Japanese source
29. Japanese source
30. Miki K. Gastric cancer screening using the serum pepshinogen test method. Gastric Cancer 2006 ; 9 : 245-53.
31. Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis 2007 ; 8 : 8-14.
32. Japanese source
33. Oishi Y, Kiyohara Y, Kubo M et al. The serum pepsinogen test as a predictor of gastric cancer. The Hisayama study. Am J Epidemiol 2006 ; 163 : 629-37.
34. Fukao A, Hisamichi A, Ohsato N et al. Correlation between the prevalence of gastritis and gastric cancer in Japan. Cancer Causes Control 1993 ; 4 : 17-20.
35. Kabuto M, Imai H, Tsugane S et al. Correlation between atrophic gastritis prevalence and gastric cancer mortality among middle-aged men in 5 areas in Japan. J Epidemiol 1993 ; 3 : 35-9.
36. Japanese source
37. Miki K, Ichinose M, Yahagi N et al. Efficiency of gastric cancer screening system using serum pepsinogen test. Progress in Gastric Cancer Research 1997, Proceedings of the 2nd International Gastric Cancer Congress Munich 1997, eds Siewert J A, Roder J D, Monduzzi Editore, Bologna 1997 ; 87-93.
38. Ohata H, Kitauchi S, Yoshimura N et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004 ; 109 : 138-43.
39. Japanese source
40. Proceeding of the 13th Annual Meeting of the Japanese Society for Helicobacter Research, 2007 ; 139.
41. Miki K, Yoshihara M, Ichinose M. Gastric cancer screening combining assay of Helicobacter pylori (Hp) antibody and pepsinogen (PG). Proceedings of the 5th Sino-Japan Workshop on Digestive Endoscopy and Gastroenterology, 2007.
42. Miki K, Yahagi N, Fujishiro M et al. High risk strategy for stomach cancer screening. Proceeding of the 15th United European Gastroenterology Week, Paris, 2007.
43. Japanese source
44. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nature Reviews 2004 ; 4 : 688-94.
45. Nomura AMY, Kolonel LN, Miki K et al. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii. J Infect Dis 2005 ; 191 : 2075-81.
46. Sasazuki S, Inoue M, Iwasaki M et al. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women : A nested case-control study. Cancer Epidemiol Biomarkers Prev 2006 ; 15 : 1341-7.
47. Con SA, Valerin AL, Takeuchi H et al. Helicobacter pylori CagA status associated with gastric cancer incidence rate variability in Costa Rican regions. J Gastroenterol 2006 ; 41 : 632-7.
48. Yahagi N, Fujishiro M, Kakushima N et al. Endoscopic submucosal dissection for early gastric cancer using the tip of an electro-surgical snare (thin type). Dig Endosc 2004 ; 16 : 34-8.
49. Yahagi N, Fujishiro M, Imagawa A et al. Endoscopic submucosal dissection for the reliable en block resection of colorectal mucosal tumors. Dig Endosc 2004 ; 16 : S 89-92.
50. Fujishiro M, Yahagi N, Kakushima N et al. Early detection of asymptomatic gastric cancers using serum pepsinogen levels to indicate endoscopic submucosal dissection for better quality of life. Proceeding of the 6th International Gastric Cancer Congress, Yokohama 2005, eds Kitajima M, Otani Y, Monduzzi Editore, Bologna 2005 ; 145-50.
51. Japanese source
52. Japanese source
53. Japanese source
54. Japanese source
55. Japanese source